AC Immune SA (ACIU)
2.51
-0.04
(-1.57%)
USD |
NASDAQ |
Oct 09, 16:00
2.51
0.00 (0.00%)
After-Hours: 20:00
AC Immune Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -20.74M |
| September 30, 2025 | -24.30M |
| June 30, 2025 | -20.69M |
| March 31, 2025 | -20.93M |
| December 31, 2024 | 5.900M |
| September 30, 2024 | -12.73M |
| June 30, 2024 | 80.70M |
| March 31, 2024 | 1.171M |
| December 31, 2023 | -18.04M |
| September 30, 2023 | -15.65M |
| June 30, 2023 | -16.24M |
| March 31, 2023 | -18.16M |
| December 31, 2022 | -18.22M |
| September 30, 2022 | -13.93M |
| June 30, 2022 | -19.11M |
| March 31, 2022 | -25.05M |
| December 31, 2021 | -19.13M |
| September 30, 2021 | -15.48M |
| June 30, 2021 | -17.51M |
| March 31, 2021 | -19.14M |
| December 31, 2020 | -22.20M |
| Date | Value |
|---|---|
| September 30, 2020 | -18.16M |
| June 30, 2020 | -15.48M |
| March 31, 2020 | -10.00M |
| December 31, 2019 | -13.15M |
| September 30, 2019 | 18.11M |
| June 30, 2019 | -15.38M |
| March 31, 2019 | 66.19M |
| December 31, 2018 | -11.41M |
| September 30, 2018 | -12.07M |
| June 30, 2018 | -6.703M |
| March 31, 2018 | -14.08M |
| December 31, 2017 | 7.168M |
| September 30, 2017 | -8.301M |
| June 30, 2017 | -9.407M |
| March 31, 2017 | -11.84M |
| December 31, 2016 | -6.941M |
| September 30, 2016 | 8.725M |
| June 30, 2016 | 0.3089M |
| March 31, 2016 | -7.733M |
| December 31, 2015 | -6.977M |
| September 30, 2015 | 34.44M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Precigen, Inc. | -17.81M |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| Aldeyra Therapeutics, Inc. | -4.589M |
| BeOne Medicines Ltd. | 463.60M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -36.43% |